APA (7th ed.) Citation

Lake, J., McComsey, G., Hulgan, T., Wanke, C., Mangili, A., Walmsley, S., . . . Currier, J. (2014). Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: The Women, Integrase and Fat Accumulation Trial. HIV Medicine, 15(7), 431. https://doi.org/10.1111/hiv.12128

Chicago Style (17th ed.) Citation

Lake, JE, GA McComsey, T. Hulgan, CA Wanke, A. Mangili, SL Walmsley, SA Stramotas, R. Tracy, and JS Currier. "Switch to Raltegravir Decreases Soluble CD14 in Virologically Suppressed Overweight Women: The Women, Integrase and Fat Accumulation Trial." HIV Medicine 15, no. 7 (2014): 431. https://doi.org/10.1111/hiv.12128.

MLA (9th ed.) Citation

Lake, JE, et al. "Switch to Raltegravir Decreases Soluble CD14 in Virologically Suppressed Overweight Women: The Women, Integrase and Fat Accumulation Trial." HIV Medicine, vol. 15, no. 7, 2014, p. 431, https://doi.org/10.1111/hiv.12128.